The Michael J. Fox Foundation Parkinson's Podcast
Summary: Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations hosted by journalist and Parkinson’s patient Dave Iverson.
- Visit Website
- RSS
- Artist: Michael J. Fox Foundation
- Copyright: Copyright 2013
Podcasts:
This fall, The FDA recommended that Teva Neuroscience's drug rasagiline, brand name Azilect, should not be granted status "to slow the clinical progression of PD."
This fall, The FDA recommended that Teva Neuroscience's drug rasagiline, brand name Azilect, should not be granted status "to slow the clinical progression of PD."
This past October, Austrian biotech AFFiRiS announced $1.5 million in funding from MJFF for an early stage clinical trial of a first-of-its-kind vaccine approach to treating Parkinson's disease (PD)
This past October, Austrian biotech AFFiRiS announced $1.5 million in funding from MJFF for an early stage clinical trial of a first-of-its-kind vaccine approach to treating Parkinson's disease (PD)
